CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
A Phase II Study to Evaluate the Safety and Efficacy of Pegteograstim in Korean Breast Cancer Patients Receiving Dose-Dense Doxorubicin/Cyclophosphamide
Gun Min Kim, Joo Hoon Kim, Ji Heung Kim, Young Up Cho, Seung Il Kim, Seho Park, Hyung Seok Park, Ji Ye Kim, Joohyuk Sohn
Cancer Research and Treatment. 2019;51(2):812-818.   Published online 2018 September 19    DOI: https://doi.org/10.4143/crt.2018.383

Excel Download

A Phase II Study to Evaluate the Safety and Efficacy of Pegteograstim in Korean Breast Cancer Patients Receiving Dose-Dense Doxorubicin/Cyclophosphamide
Cancer Research and Treatment. 2019;51(2):812-818   Crossref logo
Link1 Link2 Link3

Toxicity of Dose-Dense Docetaxel Followed by Doxorubicin with Cyclophosphamide as Adjuvant Therapy for Breast Cancer in a Phase II Study
Clinical Breast Cancer. 2007;7(9):697-704   Crossref logo
Link1 Link2

Dose-dense doxorubicin and cyclophosphamide followed by dose-dense albumin-bound paclitaxel plus bevacizumab is safe as adjuvant therapy in patients with early stage breast cancer
Breast Cancer Research and Treatment. 2011;130(3):825-831   Crossref logo
Link1 Link2 Link3

Adjuvant dose-dense doxorubicin plus cyclophosphamide followed by dose-dense nab-paclitaxel is safe in women with early-stage breast cancer: a pilot study
Breast Cancer Research and Treatment. 2010;125(1):115-120   Crossref logo
Link1 Link2 Link3

Dose Dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel (Dose Dense AC Followed by T) Regimen for Breast Cancer
Hospital Pharmacy. 2005;40(4):310-314   Crossref logo
Link1 Link2

Phase II study of dose-dense sequential doxorubicin and docetaxel for patients with advanced operable and inoperable breast cancer
Breast Cancer Research and Treatment. 2005;97(3):311-318   Crossref logo
Link1 Link2 Link3

Randomized Phase II Adjuvant Trial of Dose-Dense Docetaxel Before or After Doxorubicin Plus Cyclophosphamide in Axillary Node-Positive Breast Cancer
Breast Diseases: A Year Book Quarterly. 2009;20(2):198-199   Crossref logo
Link1 Link2

A dose-dense schedule of docetaxel followed by doxorubicin and cyclophosphamide as neoadjuvant treatment for breast cancer: results from a phase II study
Clinical and Translational Oncology. 2011;13(9):686-691   Crossref logo
Link1 Link2 Link3

Pegfilgrastim and darbepoetin alfa as haematopoietic support for adjuvant dose dense doxorubicin + cyclophosphamide-paclitaxel in early stage breast cancer patients – results from the ACCELERATE study
European Journal of Cancer Supplements. 2008;6(7):128   Crossref logo
Link1 Link2

Randomized phase II trial of high-dose 4′-epi-doxorubicin + cyclophosphamide versus high-dose 4′-epi-doxorubicin + cisplatin in previously untreated patients with extensive small cell lung cancer
Lung Cancer. 1993;10(1-2):147   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.